El Salvador vs Kyrgyzstan: Adults (ages 15+) and children (ages 0-14) newly infected with HIV
El Salvador
940
in 2024
Kyrgyzstan
920
in 2024
El Salvador rank
79th
Kyrgyzstan rank
80th
Adults (ages 15+) and children (ages 0-14) newly infected with HIV over time
- El Salvador
- Kyrgyzstan
How they compare
El Salvador currently reports 940 against 920 in Kyrgyzstan, a difference of 20.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was El Salvador ahead.
El Salvador ranks 79th and Kyrgyzstan ranks 80th of 146 countries.
Across the 4 decades both report, El Salvador averaged higher in 2 and Kyrgyzstan in 2.
Head to head by decade
| Decade | El Salvador | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1,781 | 100 | 1,681 | El Salvador |
| 2000s | 1,784 | 423 | 1,361 | El Salvador |
| 2010s | 659 | 842 | 183 | Kyrgyzstan |
| 2020s | 856 | 890 | 34 | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher adults (ages 15+) and children (ages 0-14) newly infected with hiv, El Salvador or Kyrgyzstan?
- El Salvador, at 940 against 920 in Kyrgyzstan as of 2024.
- What is the difference in adults (ages 15+) and children (ages 0-14) newly infected with hiv between El Salvador and Kyrgyzstan?
- 20, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Kyrgyzstan?
- 35 years are reported by both, from 1990 to 2024.
- How do El Salvador and Kyrgyzstan rank globally for adults (ages 15+) and children (ages 0-14) newly infected with hiv?
- El Salvador ranks 79th and Kyrgyzstan ranks 80th of 146 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Adults (ages 15+) and children (ages 0-14) newly infected with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of adults (ages 15+) and children (ages 0-14) newly infected with HIV.